Survodutide is an investigational dual GLP-1 and glucagon receptor agonist undergoing clinical evaluation for obesity and metabolic dysfunction-associated
Read more Survodutide Studies: Evaluating Dual GLP-1 and Glucagon Agonism in Clinical Research
Cagrilintide is an investigational, long-acting dual amylin and calcitonin receptor agonist. This scientific review examines its receptor pharmacology, hum
Read more Cagrilintide: Human Clinical Trials, Pharmacology, and Evidence Limitations
An evidence-based scientific review of survodutide (BI 456906), exploring its dual GLP-1 and glucagon receptor agonism, Phase 2 trial results in MASH and o
Read more Survodutide: Mechanism of Action and Clinical Trial Evidence
A comprehensive scientific overview of Cagrilintide, a novel dual amylin and calcitonin receptor agonist (DACRA), detailing its pharmacokinetics, synergist
Read more Cagrilintide as a Research Peptide: Mechanism, Synergies, and Clinical Evidence